BlackRock »

Rapt Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3M 90k 25.79
2025-06-30 $719k 90k 8.00

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Netflix (NFLX)

View all positions for BlackRock

Top funds holding Rapt Therapeutics

TCG Crossover Management
Foresite Capital Management VI
Rtw Investments
OrbiMed Advisors
Ikarian Capital
Boone Capital Management
Deep Track Capital
Vanguard Group
Nantahala Capital Management
Siren
Redmile Group
Soleus Capital Management
ADAR1 Capital Management
Fcpm Iii Services B.v.
Boothbay Fund Management

View all funds holding Rapt Therapeutics